Innate Pharma S.A. (IPHA)
NASDAQ: IPHA
· Real-Time Price · USD
2.04
-0.01 (-0.48%)
At close: Sep 08, 2025, 3:59 PM
1.97
-3.43%
After-hours: Sep 08, 2025, 04:00 PM EDT
Innate Pharma S.A. Revenue
Innate Pharma S.A. reported an annual revenue of $12.62M, reflecting a -75.68% growth. For the quarter ending December 31, 2024, Innate Pharma S.A. generated $276K in revenue.
Revenue (ttm)
12.62M
Revenue Growth
-75.68%
Price / Sales Ratio
11.41
Revenue / Employee
69.73K
Employees
181
Market Cap
165.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 12.62M | -75.68% |
| Dec 31, 2023 | 51.9M | -10.01% |
| Dec 31, 2022 | 57.67M | +376.17% |
| Dec 31, 2021 | 12.11M | -82.64% |
| Dec 31, 2020 | 69.77M | +1.16% |
| Dec 31, 2019 | 68.97M | -13.67% |
| Dec 31, 2018 | 79.89M | +144.83% |
| Dec 31, 2017 | 32.63M | -41.90% |
| Dec 31, 2016 | 56.16M | +213.64% |
| Dec 31, 2015 | 17.91M | +1874.20% |
| Dec 31, 2014 | 907K | -92.73% |
| Dec 31, 2013 | 12.47M | +20.16% |
| Dec 31, 2012 | 10.38M | -11.61% |
| Dec 31, 2011 | 11.74M | +171.76% |
| Dec 31, 2010 | 4.32M | -44.01% |
| Dec 31, 2009 | 7.72M | -40.30% |
| Dec 31, 2008 | 12.92M | -9.56% |
| Dec 31, 2007 | 14.29M | +130.67% |
| Dec 31, 2006 | 6.2M | +376.54% |
| Dec 31, 2005 | 1.3M | n/a |